Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
1 hedge funds and large institutions have $0 invested in Sophiris Bio, Inc. in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less capital invested
Capital invested by funds: $71K → $0 (-$71K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hikari Power
Tokyo,
Japan
|
-$70K |
| 2 |
ACM
AUA Capital Management
Camp Hill,
Pennsylvania
|
-$1K |
SPHS Hedge Fund Activity: Q2 2020 in Review
1 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q2 2020, worth a combined $0 — down 100% from $71K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SPHS and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Hikari Power, exiting entirely with an estimated $70K sold.
- 1 institutional investor held Sophiris Bio, Inc. (SPHS) as of Q2 2020, down from 3 in Q1 2020.
- Funds reported $0 of Sophiris Bio, Inc. stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new Sophiris Bio, Inc. positions in Q2 2020 and 2 closed out, a net change of -2 holders.
- The largest Sophiris Bio, Inc. seller in Q2 2020 was Hikari Power, an estimated $70K sold.
Based on aggregated 13F filings for Q2 2020.